Status:

COMPLETED

Optimizing Music-Based Interventions for Stroke

Lead Sponsor:

NYU Langone Health

Collaborating Sponsors:

National Institutes of Health (NIH)

Conditions:

Stroke

Eligibility:

All Genders

18-89 years

Phase:

NA

Brief Summary

This study will enroll stroke patients and healthy participants. Participants will complete baseline measures followed by a music playing task during fMRI and simultaneous measurement of motor respons...

Eligibility Criteria

Inclusion

  • For participants with stroke, to be eligible to participate in this study, an individual must meet all the following criteria:
  • hemiparesis resulting from a stroke (ischemic or hemorrhagic) at least 6 months before the enrollment into the study
  • age from 18 to 89 years
  • ability to move the wrist flexor and extensor muscles without help from the healthy side, scoring above 3 on the Medical Research Council (MRC) Scale for Muscle Strength, reflecting active movement against gravity
  • no more than mild resistance to passive movement in the wrist extensor muscle - as demonstrated by a score \<2 on the Ashworth Scale (Brashear et al.., 2002)
  • a modified Rankin Scale (mRS) \< 3 indicating moderate to mild disability and the ability to ambulate independently (Bonita \& Beaglehole, 1988)
  • ability to comprehend language and provide informed consent
  • consenting to participate and willingness to complete MRI testing procedures
  • For neurologically normal control (NC) participants, to be eligible to participate in this study, an individual must meet all the following criteria:
  • be matched for age, gender, and socioeconomic status (education level) to a previously enrolled participant with stroke
  • age from 18 to 89 years
  • no history of neurological injury
  • ability to comprehend language and provide informed consent
  • consenting to participate and willingness to complete MRI testing procedures

Exclusion

  • history of neurological injury other than stroke
  • moderate to severe depression symptoms indicated by a score \>10 on the Patient Health Questionnaire - 9 (PHQ-9; Koenke et al., 2001; Williams et al., 2005)
  • visual impairment unable to be corrected with glasses/contact lenses sufficient to allow reading comprehension
  • actively performing or practicing a musical instrument more than 2 hours/week
  • musical anhedonia indicated by a score \< 65 on the Barcelona Music Reward Questionnaire (BMRQ; Mas-Herrero et al., 2013)
  • amusia as measured by the Montreal Battery of the Evaluation of Amusia (MBEA; Peretz et al., 2003)
  • not being compatible with MRI testing, including having implanted devices, previous exposure to metallic fragments, large tattoos, claustrophobia, and pregnancy

Key Trial Info

Start Date :

February 16 2024

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 8 2025

Estimated Enrollment :

26 Patients enrolled

Trial Details

Trial ID

NCT06215703

Start Date

February 16 2024

End Date

February 8 2025

Last Update

April 25 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

NYU Langone Health

New York, New York, United States, 10016